Neil A. Christie
University of Pittsburgh, University of Pittsburgh Medical Center
Papers
5
Total Citations
127
H-Index
4
About
Dr. Neil A. Christie is a leading thoracic surgeon whose research focuses on advancing minimally invasive and robotic-assisted surgical techniques for complex thoracic malignancies. His work has fundamentally shaped the management of lung cancer, esophageal cancer, and myasthenia gravis. Dr. Christie’s most impactful contribution is his pioneering work on fractionated stereotactic body radiation therapy (SBRT) for lung tumors, where he demonstrated the critical role of PET/CT-based treatment planning—a study that has earned 85 citations and influenced radiation oncology protocols worldwide. He is also a key figure in the robotic surgery revolution, with his 2022 propensity-matched study on robotic-assisted minimally invasive esophagectomy (25 citations) providing high-volume, single-institution evidence for improved outcomes over traditional approaches. Further, his investigation into the association between robotic lobectomy volume and nodal upstaging in non-small cell lung cancer (9 citations) highlights the importance of surgical expertise in achieving accurate staging. Dr. Christie has also advanced thymectomy techniques, notably developing a robotic-assisted approach with simultaneous bilateral thoracoscopy for enhanced contralateral phrenic nerve visualization, and has contributed to the debate on surgery versus medical therapy for non-thymomatous myasthenia gravis. His work consistently bridges surgical innovation with improved patient outcomes, making him a respected authority in thoracic oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5